CONSULTINGServices EN NL
Jacques
TIMMERMANS
  Professional profile
LIFE SCIENCES, PHARMA, HOSPITAL & HEALTHCARE
E N G L I S H   F R A N Ç A I S   N E D E R L A N D S
Short
CV
< Detailed
profile
>   CV
résumé
| Profil
détaillé
  Kort
CV
| Uitgebreid
profiel
Previous  Home Profile - Menu Consulting Documents  Next
<  DETAILED  PROFESSIONAL  PROFILE  -  TABLE  OF  CONTENTS  >
     PERSONAL  DATA      EDUCATION  
 

  Personal data

 

  Education, experience

 
 

  Awards, citations

 

  People & Project management (trainings)

 
 

  Personal interests and hobbies

 

  Quality Assurance & Regulatory Affairs

 
 
   CAREER  &  EXPERTISE
 
   RELATIONS  &  COMMUNICATION
 
 

  Career overview

 

  Memberships

 
 

  Consulting services

 

  Lectures & Presentations

 
 

  Job description of last occupations

 

  Patents (designation as inventor)

 
 

  Transferable skills

 

  Articles and publications

 
 

  Professional references

 

 
         
 
 •  Personal data
Return to menu ] 

 Name, first name :

TIMMERMANS, Jacques

 Date, place of birth :

Uccle (Brussels, Belgium, Europe) on December 18, 1956

 Nationality :

Belgian

 Languages :

Mother tongue(s) : French-speaking father, Dutch(Flemish)-speaking mother, education in french

 

English : written and spoken fluently

 Civil status :

Statutory cohabitation, two children (1994, 1997)

 Home address :

Rue Cardinal Mercier 66, B-1460 Virginal Ittre, Belgium

 E-mail :

jacques.timmermans@skynet.be

 Web site :

www.jacquestimmermans.com

 Linkedin profile :

www.linkedin.com/in/jacquestimmermans

 

Privacy statement : sensitive information (e.g. telephone numbers and other personal details that may be easily abused) is not disclosed on this web page. For any further details you should need, please contact the owner by post or e-mail.
 

 •  Education, experience
Return to menu ] 

  1984 – 1991 :

Doctor (Ph.D.) in Pharmaceutical Sciences
Université Libre de Bruxelles (ULB, Brussels, Belgium),
Faculty of Medicine and Pharmacy - School of Pharmacy,
Dept. of Pharmaceutics and Biopharmacy

Director of thesis: Pr A.J. Moës,
Title : Floating hydrophilic matrix dosage forms for oral use : factors controlling their buoyancy and gastric residence capabilities.

[Summary of Ph.D. thesis]
Proclaimed "with highest honour and congratulations of the jury,
Cum Laude
"
on 4th July 1991

 1986 :

Industry Pharmacist
Inscription on Belgian list (registration number: 1092) obtained on 4th November 1986, Belgian Monitor of 10.02.1987

Responsible person for pharmaceutical information and publicity relating to medicinal products for human use [articles 13 and 14, Royal Decree of 7 April 1995], Federal Agency for Medicines and Health Products (FAMHP / AFMPS - FAGG).
Agreement number : 904 (16.10.2012)

 1984 :

Registered Bandagist, supplier of prostheses and implants
(INAMI-RIZIV)
Certificate (for articles 27 and 28) obtained on 1st May 1984
Registration number as bandagist : 1-6-26234-95-201
Registration number as supplier of prostheses and implants : 6-30473-27-300

  1981 – 1983 :

Hospital Pharmacist
Université Libre de Bruxelles (ULB, Brussels, Belgium),
Faculty of Medicine and Pharmacy - School of Pharmacy,
Directors of thesis:
Pr J. Reuse, Pharmacology Department, ULB, Brussels.
Pr A. De Wever, Medical Director, Erasme Hospital, Brussels
Title : Development of a hospital pharmacovigilance program

Proclaimed "with great honour"
on 10th January 1984

Accreditation to the professional title of Hospital Pharmacist
Registration number : FT03000430 (20.06.2011)

  1974 – 1981 :

Pharmacist (Pharm.D.)
Université Libre de Bruxelles (ULB, Brussels, Belgium),
Faculty of Medicine and Pharmacy - School of Pharmacy,

Director of thesis: Pr M. Van Haelen, Pharmacognosy Department
Title : Saxitoxin (STX) and Tetrodotoxin (TTX) : two similar neuropoisons isolated from marine animals (and their potential applications to medicine)

Proclaimed "with great honour"
on 26th June 1981
Registration number of national convention (INAMI-RIZIV) : 2-08387-66-002

  1967 – 1974 :

Classical education (Latin-Sciences)
Athénée Royal de Bruxelles II, B-1020 Brussels, Belgium.
 

 •  People & Project management (trainings)
Return to menu ] 

 1999 :

Management By Objective (MBO)
A.-S. Colemont (ACT), Belgium

 1999 :

Research project team management
(empowerment, partnership, commitment, team building)
J. Hamels (Training Manager, UCB Human Resources),
Demol, Dewandre (Lead Group International - the Consulting Group), Belgium

 1998 :

Portfolio Project Management (PPM)
A. Bernier (UCB, PPM Group), with the support of PricewaterhouseCoopers, Belgium

 1995 :

Human Resources
(social legislation, conflict management)
G. Van Der Beken (UCB, Human Resources),
Ch. Portois (UCB, Human Resources - Corporate), Belgium

 1994 :

People management
(transactional analysis, delegation, coaching, management / leadership)
R. Moyson (Management Training Team),
F. Oidtmann (IBM Skillteam), Belgium
 

 •  Quality Assurance & Regulatory Affairs (trainings)
Return to menu ] 

 2018 :

Responsible Person GDP
Responsible Person - Good Distribution Practices (GDP)
for Medicinal Products,
K. Bindus (Quastion learning services/Qplus consult), Belgium

 2013 :

EN ISO 13485 Standard
EN ISO 13485:2012 - Medical devices
Quality management Systems - Requirements for regulatory purposes,
R. Brendel (Quasys / CQHN), Belgium

 2012 :

Internal audit ISO 9001 Standard
Conduct of internal audit according to ISO 9001:2008
Quality management systems - Requirements
L. Lekeu (Vinçotte Academy), Belgium
 

 •  Awards, citations
Return to menu ] 

 since 1998 :

Biographical profile cited in several Marquis Who’s Who, NJ, USA :
"Who’s Who in the World" since 15th Edition
"Who’s Who in Science and Engineering" since 4th Edition
"Who’s Who in Medicine and Healthcare" since 2nd Edition

 1991 :

Laureate of the 5th section 1989 competition of the Belgian Royal Academy of Medicine
Title : Comparative evaluation of the gastro-intestinal transit of floating and non-floating matrix dosage forms.  [Abstract  [Publication]
Director of work: Pr A.J. Moës, ULB, Brussels
 

 •  Career overview
Return to menu ] 

  08.2012 – present :

Quality Assurance & Regulatory Affairs Manager
(Medical Devices Distribution)
Hospithera sa/nv, Brussels,
reporting to General Management
: Ph. Van den Bogaert
Head office : rue de la Petite-Île 3, B-1070 Brussels, Belgium
(summary job description )

  11.2007 – present :

Independent Senior Consultant (Hospital & Healthcare, Pharma Industry)
Jacques Timmermans [Ph.D., Pharm.Sci.], Consulting Services (Freelance)

Home Office : rue Cardinal Mercier 66, B-1460 Ittre, Belgium
Home page · Info · Contact

  01.2011 – 12.2011 :

Head of Pharmacy Services (hospital setting)
Groupe Hospitalier La Ramée-Fond’Roy, B-1180 Brussels (part-time employment), reporting to General Management
,
Managing Director : Dr M. Derély
Medical Director : Dr E. Debersaques
(summary
job description )

  10.2005 – 09.2007 :

Adviser to the General Management (hospital setting)
Hospital network of « CHU-UVC Brugmann » and « HUDERF-UKZKF - University Children Hospital Queen Fabiola » (IRIS network / ULB-VUB, Brussels),
reporting to the General Management
,
Managing Director : Pr D. Désir
Medical Director : Pr G. Casimir
Head office : place A. Van Gehuchten 4, B-1020 Brussels, Belgium
(summary
job description )

  05.2005 – 09.2005 :

Project leader « Infohos, IHCgroup / Pharmacy software package »
Clinique Saint-Jean - Sint-Jan Kliniek, Boulevard Jardin Botanique 32, Brussels, reporting to the General Management
,
Managing Director : Dr P. Gérard
Medical Director ad interim : Dr G. Hanique
(summary
job description )

  02.2003 – 04.2005 :

Managing Director/Coordinator of the Pharmacy Departments (hospital setting)
Network of « Centres Hospitaliers de Jolimont - Lobbes, Tubize - Nivelles »,
reporting to the General
Director : C. Faucon
Head office : rue Ferrer 159, B-7100 Haine-Saint-Paul, Belgium
(summary
job description )

  11.1991 – 09.2003 :

Scientific Fellow at the University, ULB, Brussels, Belgium
Faculty of Medicine and Pharmacy, School of Pharmacy,
Department of Pharmaceutics, industry pharmacy and biopharmacy,
Head of Dept.: Pr A.J. Moës
(summary job description )

  07.2001 – 01.2003 :

Internal Auditor & Quality Assurance (Q.A.) Adviser (hospital setting)
CUB Erasme Hospital, ULB
Route de Lennik 808, Brussels, Belgium
(summary job description )

 

Audit and Q.A. of pricing & invoicing operations (02.2002 – 01.2003),
reporting to General Management,
Medical Director : Pr J.-C. Yernault
Managing Director : Pr S. Lejeune

 

Audit and Q.A. of pharmaceutical operations (07.2001 – 12.2001),
r
eporting to Pharmacy Department,
Head of Dept.: D. Even-Adin

  01.1991 – 11.2000 :

Head of Preformulation Laboratory, Preclinical R&D (pharmaceutical industry)
UCB S.A., Pharma Sector, Research & Development,
Preformulation Laboratory R&D,

Department of Product Safety & Metabolism
,
Chemin du Foriest, B-1420 Braine l'Alleud, Belgium
Head of DMPK Laboratory : E. Baltes
Head of Dept.: J. Roba
(summary job description )

 1990 :

Invited National Pharmacovigilance Expert for Belgium
European Commission (EC), Brussels,

designated for the Meetings of the "ad hoc group on Pharmacovigilance" of the Committee of Proprietary Medicinal Products (CPMP), Commission of the European Communities
(summary job description )

  02.1987 – 01.1988 :

Laboratory & Clinical Unit Supervisor (clinical studies in hospital setting)
Clinical Pharmacology Dept., CUB Erasme Hospital, ULB

Route de Lennik, 808, B-1070 Brussels
Head of Dept.: Dr D. Gangji
(summary job description )

  12.1981 – 01.1987  
02.1988 – 12.1990 :

Hospital Pharmacist (acting Head : 05.83 – 08.83)
Pharmacy Department., CUB Erasme Hospital, ULB,
Route de Lennik, 808, B-1070 Brussels
Head of Dept.: Ph D. Even-Adin
(summary job description )
 

 •  Consulting services
Return to menu ] 

  since 12.2007 :

Professional occupation as service provider (independent senior consultant), see detailed section
 

 •  Job description of last occupations
Return to menu ] 

 

See detailed section
 

 •  Professional references
Return to menu ] 

 

See summary list
 

 •  Memberships
Return to menu ] 

 since 2009 :

Mensa International (Belgium)

 since 2003 :

Association Francophone des Pharmaciens Hospitaliers de Belgique (AFPHB)

  1990 – 2003 :

Belgian Society of Pharmaceutical Sciences

  1993 – 2002 :

Pharmaceutical Association of Industry Pharmacists (UPIP - VAPI, Belgium)

  1984 – 1992 :

European Society of Clinical Pharmacy

  1983 – 1992 :

Association Belge des Pharmaciens Hospitaliers
 

 •  Transferable skills
Return to menu ] 

 

See detailed section
 

 •  Personal interests and hobbies
Return to menu ] 

 

  Family and friends.
  Listening and playing music.
  Writing of short stories.
  Sport : Alpine skiing, inline roller skate, martial arts.
 

 •  Lectures & Presentations
Return to menu ] 

 12.2006 :

Timmermans J.,
La forfaitarisation des médicaments.
GLEM/LOK (Local group of medical evaluation, peer-review), Department of Orthopaedic Surgery, CHU-UVC Brugmann - Horta site, Brussels, Belgium

 10.2006 :

Timmermans J.,
Forfaitarisation hospitalière et répercussions potentielles en médecine générale.
Continuing education session of the Scientific Society of General Medicine (Société Scientifique de Médecine Générale, SSMG), Brussels, Belgium

  05.2006 – 08.2006 :

Timmermans J., Défrade J.,
Prospective financing system for drug reimbursement to the hospital.
Campaign of information sessions for the medical, nursing and managing staff.
Hospital network of CHU-UVC Brugmann and HUDERF-UKZKF, IRIS network / ULB - VUB, Brussels, Belgium
[PowerPoint presentation]

  09.2004 – 11.2004 :

Timmermans J.,
Training sessions for the Pharmacy staff of the hospital network of
Centres Hospitaliers de Jolimont-Lobbes, Tubize-Nivelles to the use
of the software "INFOHOS" - IHC group - Bruges, Belgium

  Academic years  
 1997 – 2003 :

Timmermans J.,
Lecturer on "Pharmaceutical Preformulation" for the D.E.S. students in Industry Pharmacy of the inter-university program between Brussels (ULB), Liège (ULg) and Louvain (UCL) - Belgium

  11.2001 – 12.2001 :

Timmermans J.,
La Qualité, c'est quoi ?
Quality Assurance continuing education sessions for the Pharmacy staff,  Hôpital Erasme, Cliniques Universitaires de Bruxelles, Belgium
[PowerPoint presentation]

 10.1994 :

Timmermans J.,
Gamma-scintigraphy in the exploration of the gastro-intestinal transit and relation with absorption kinetics.
VAPI-UPIP continuing education session on the future of orally administered drugs, Capsugel, Bornem, Belgium

  08.1989 :

Timmermans J., Franz M.,
Design of a controlled release floating dosage form:
In vitro - In vivo considerations.
Searle & Co., Pharmaceutical Development Meeting, Chicago, USA

 02.1989 :

Timmermans J.,
Summary of a two-year research program on controlled release floating dosage forms.
Searle & Co., European Development Center, Mont-St-Guibert

  02.1989 :

Timmermans J., Van Gansbeke B.,
Mesure du temps de vidange gastrique de formes galéniques matricielles.
Séminaire du Service de Médecine Nucléaire,
Hôpital Erasme, Cliniques Universitaires de Bruxelles

 01.1988 :

Timmermans J.,
Le rôle d'un centre de pharmacovigilance hospitalier.
Conférence du Service de Médecine,
Centre Hospitalier Universitaire de Tivoli, La Louvière

  06.1987 :

Timmermans J.,
La pharmacovigilance hospitalière.
Conférence de Formation Médicale Continue des médecins généralistes,
Centre Universitaire de Médecine Générale, U.L.B., Mons

 05.1987 :

Timmermans J.,
Development of a resultant-weight apparatus and method.
Selection of appropriate radiopharmaceuticals for in vivo gamma scintigraphic monitoring study.
Searle & Co., European Development Center, Mont-St-Guibert

  02.1986 – 05.1986 :

Timmermans J., Gangji D.,
La pharmacovigilance: A la recherche de Mister ADR.
Cycle des Sessions de Formation du personnel soignant de l'Hôpital Erasme,
Cliniques Universitaires de Bruxelles
 

 •  Patents (designation as inventor)
Return to menu ] 

 

  1. Timmermans J., Moës A.J.,
    Apparatus and method for resultant-weight measuring system.
    United States Patent 5,076,107 (1991).

  2. Bodson G., Timmermans J.,
    New pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl) methyl -1-piperazinyl ethoxy acetic acid dihydrochloride.
    [European Patent Application 97870193.6-2101 (1997)].

  3. Lamberty Y., Timmermans J., Waegemans T., Bodson G.,
    2-(2-(4-((2R)-2-methyl-3-(10H-phenothiazin-10-yl)propyl)-1-piperazinyl)-ethoxy) ethanol, process for the preparation thereof, pharmaceutical compositions containing said compound and therapeutic uses thereof.
    European Patent Application 00127741.7 (2000).

  4. Berwaer M., Bodson G., Deleers M., Dogimont C., Fanara D., Timmermans J.,
    Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl) methyl] -1-piperazinyl] ethoxy] acetic acid dihydrochloride.
    European Patent 1 034 171 B1 (2001).

  5. Lamberty Y., Timmermans J., Waegemans T., Bodson G., Broeders F.,
    2-(2-(4-((2R)-2-methyl-3-(10H-phenothiazin-10-yl)propyl)-1-piperazinyl)-ethoxy) ethanol, process for the preparation thereof, pharmaceutical compositions containing said compound and therapeutic uses thereof.
    United States Patent Application 10/433,832
    International Application Number PCT/EP01/13227 (2001).
     

 •  Articles and publications
Return to menu ] 

 

  1. Timmermans J.,
    Saxitoxine et Tetrodotoxine: Deux neuropoisons similaires extraits d'animaux marins.
    A. Pha. Br. 34, 9: 3-13 (1982).

  2. Timmermans J.,
    Développement des activités de pharmacovigilance en milieu hospitalier.
    Mémoire présenté en vue de l'obtention du titre de Pharmacien hospitalier,
    Institut de Pharmacie, U.L.B., Bruxelles (1983).

  3. Timmermans J.,
    Advantages for the pharmacy department of a computerized calculating system for neonates parenteral nutrition.
    Proceed. 13th Symp. Clinical Pharmacy: computer technology and clinical pharmacy
    (computer in practice: abstract 26) Eur. Soc. Clin. Pharm.,
    UK Clin. Pharm. Assoc., Bournemouth, UK (1984).

  4. Timmermans J.,
    Pharmacovigilance hospitalière: Surveillance d'un médicament au-dessus de tout soupçon.
    XVIème Congrès Hopex 85, Liège, Belgique,
    L'Hôpital Belge 28, 173: 56-64 (1985).

  5. Timmermans J., Gangji D.,
    Tintin à la rescousse de la pharmacovigilance.
    Pharmakon 61: 7-19 (1985).

  6. Neve J., Molle L., Timmermans J.,
    Importance du sélénium en alimentation parentérale totale.
    Pharmakon 62: 95-105 (1985).

  7. Timmermans J.,
    Advantages for the pharmacy department of a computerized calculating system for neonates parenteral nutrition.
    In Progress in Clinical Pharmacy VII, Clinical Pharmacy and Computer Technology,
    J.W. Poston, Swedish Pharmaceutical Press, Stockholm, 224-234 (1985).
     [Abstract  [Publication]

  8. Pardou A., Timmermans J., Even-Adin D.,
    Use of a microcomputer at the pharmacy level to improve total parenteral nutrition processing in a neonatal intensive care unit.
    J. Pharm. Clin. 4, 4: 563-571 (1985).
     [Abstract  [Publication]

  9. Timmermans J.,
    Editorship of: Thrombose veineuse profonde: Nouvelles perspectives dans le domaine de la prévention. Sandoz Symposium, French Ed., Rosière, Belgique, 5-20 (1986).

  10. Van Gansbeke B., Timmermans J.,
    Photosensibilité et stabilité des solutions aqueuses d'éosine.
    J. Pharm. Clin. 5, 3: 313-319 (1986).

  11. Ingani H.M., Timmermans J., Moës A.J.,
    Conception and in vivo investigation of peroral sustained release floating dosage forms with enhanced gastrointestinal transit.
    Int. J. Pharm. 35: 157-164 (1987).

  12. Timmermans J.,
    Le phénomène d'adsorption appliqué au charbon activé: A propos de son utilisation comme antidote par voie orale. I. Choisir, connaître et préparer un charbon détoxifiant.
    Pharmakon 71: 89-95 (1987).

  13. Timmermans J., Gangji D.,
    Looking for Mister ADR ..: Efficacy of an awareness campaign on adverse drug reaction (ADR) reporting.
    W.H.O. drug utilization research group meeting, Oslo, Sept. 1987,
    Pharm. Weekbl. Sci. Ed. 9, 6: 330 (1987).

  14. Timmermans J.,
    Le phénomène d'adsorption appliqué au charbon activé: A propos de son utilisation comme antidote par voie orale. II. Administrer pourquoi, quand, combien et comment?
    Pharmakon 73: 29-37 (1988).

  15. Timmermans J., Moës A.J.,
    Determining in vitro the resultant-force acting on a pharmaceutical form immersed in a fluid: An apparatus and a method.
    Proceed. APGI 5th International Conference on Pharmaceutical Technology,
    Paris, France, 2: 294-303 (1989).

  16. Timmermans J., Moës A.J.,
    Various applications of an apparatus determining in vitro the resultant-force acting on a pharmaceutical dosage form immersed in a fluid.
    Proceed. APGI 5th International Conference on Pharmaceutical Technology,
    Paris, France, 1: 22-31 (1989).

  17. Timmermans J., Van Gansbeke B., Moës A.J.,
    Assessing by gamma scintigraphy the in vivo buoyancy of dosage forms having known size and floating force profiles as a function of time.
    Proceed. APGI 5th International Conference on Pharmaceutical Technology,
    Paris, France, 1: 42-51 (1989).

  18. Timmermans J., Van Gansbeke B., Oth M., Franz M., Moës A.J.,
    Gastric residence time determinations of floating vs. non-floating matrices correlated with in vitro measured size and resultant-force kinetics.
    Proceed. 16th Intern. Symp. Control. Rel. Bioact. Mater., Controlled Release Society Inc., Chicago, USA, 60-61 (1989).
     [Abstract]

  19. Tielemans C., Knoop C., Doutrelepont J.M., Timmermans J., Even-Adin D., Vanherweghem J.L.,
    Superiority of calcium acetate (ACET) over carbonate (CARB) to bind phosphorus (P) in hemodialysis patients (HDP).
    Proceed. 11th Intern. Cong. Nephrology, Tokyo, Japan (1990).

  20. Timmermans J., Van Gansbeke B., Moës A.J.,
    Optimizing the buoyancy of oral floating dosage forms to improve reliability of gastric retention.
    2ème Forum des Sciences Pharmaceutiques, De Haan,
    J. Pharm. Belg. 45, 1: 76 (1990).

  21. Timmermans J., Moës A.J.,
    Measuring the resultant-weight of an immersed test material:
    I. Validation of an apparatus and a method dedicated to pharmaceutical applications.
    Acta Pharm. Technol. 36, 3: 171-175 (1990).
     [Abstract]

  22. Timmermans J., Moës A.J.,
    Measuring the resultant-weight of an immersed test material:
    II. Examples of kinetic determinations applied to monolithic dosage forms.
    Acta Pharm. Technol. 36, 3: 176-180 (1990).
     [Abstract]

  23. Timmermans J., Moës A.J.,
    How well do floating dosage forms float ?
    Int. J. Pharm. 62: 207-216 (1990).
     [Abstract  [Publication]

  24. Timmermans J.,
    Evaluation comparative du transit gastrique de formes pharmaceutiques matricielles flottantes et non-flottantes.
    Bull. Acad. Méd. Bel. 145, 8-9: 365-375 (1990).
     [Abstract  [Publication]

  25. Timmermans J.,
    Floating hydrophilic matrix dosage forms for oral use:
    Factors controlling their buoyancy and gastric residence capabilities.
    Thèse présentée en vue de l'obtention du titre de Docteur en Sciences Pharmaceutiques,
    Université Libre de Bruxelles (1991).
     [Abstract]

  26. Van Gansbeke B., Timmermans J., Schoutens A., Moës A.J.,
    Intragastric positioning of two concurrently ingested pharmaceutical matrix dosage forms.
    Nucl. Med. Biol. (Int. J. Radiat. Appl. Instrum. Part B)
    18, 7: 711-718 (1991).
     [Abstract]

  27. Timmermans J., Moës A.J.,
    Factors controlling the buoyancy and gastric residence capabilities of floating hydrophilic matrix dosage forms for oral use.
    B.T. Gattefossé 84: 53-70 (1991).

  28. Oth M., Franz M., Timmermans J., Moës A.,
    The bilayer floating capsule: A stomach-directed drug delivery system for Misoprostol.
    Pharm. Res. 9, 3: 298-302 (1992).
     [Abstract]

  29. Timmermans J., Moës A.J.,
    The cutoff size for gastric emptying of dosage forms.
    J. Pharm. Sci. 82, 8: 854 (1993).

  30. Timmermans J., Moës A.J.,
    Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: New data for reconsidering the controversy.
    J. Pharm. Sci. 83, 1: 18-24 (1994).
     [Abstract]

  31. Timmermans J., Liévin V., Moës A.J.,
    Disintegration kinetics of tablets monitored by means of a resultant-weight apparatus.
    S.T.P. Pharma. Sciences 5, 2: 110-115 (1995).
     [Abstract]

  32. Amighi K., Timmermans J., Puigdevall J., Baltes E., Moës A.J.,
    Peroral sustained-release film-coated pellets as a means to overcome physicochemical and biological drug-related problems. I. In vitro development and evaluation.
    Drug Dev. Ind. Pharm. 24, 6: 509-515 (1998).
     [Abstract]

  33. Timmermans J., Amighi K., Puigdevall J., Baltes E., Moës A.J.,
    Peroral sustained-release film-coated pellets as a means to overcome physicochemical and biological drug-related problems. II. Bioavailability and tolerance assessment in dogs.
    Drug Dev. Ind. Pharm. 24, 6: 517-525 (1998).
     [Abstract]

  34. Timmermans J.,
    Forfaitarisering van ziekenhuisgeneesmiddelen : waarom, voor wie, hoe, wat staat er ons te doen ...?

    Medi-Sfeer 274: 6-10 (2006).  [Abstract  [Publication]
    Gunaïkeia 11, 6: 180-183 (2006).
    BHL 11, 6: 175-178 (2006).
    Andrologic 2, 5: 121-125 (2006).

  35. Timmermans J.,
    La forfaitarisation des médicaments à l'hôpital : pourquoi, pour qui, comment, ... que faire ?
    Big Jim 30: 6-9 (2006).
    Medi-Sphere 274: 6-10 (2006).  [Abstract  [Publication]
    Gunaïkeia 11, 6: 180-183 (2006).
    VCP 11, 6: 175-178 (2006).
    Andrologic 2, 5: 121-125 (2006).
    Ortho-Rhumato 4, 6: 191-194 (2007).

  36. Timmermans J.,
    Infections nosocomiales : améliorer le diagnostic.
    Le Pharmacien 23, 12 (2008).
     [Abstract
     [Publication]

  37. Timmermans J.,
    Meilleurs voeux de santé aux établissements de santé !
    Refinancement prioritaire et sans condition du secteur hospitalier.
    Tendances pour Spécialistes 1, 4 (2009).
     [Abstract  [Publication]

  38. Timmermans J.,
    Numerus clausus : mauvais diagnostic, mauvais remède ?
    Tendances pour Spécialistes 2, 4 (2009).  [Abstract  [Publication]
     

 
Previous page  Home Top of page  Next page

Professional profile - Curriculum Vitae - Career Resume of Dr Jacques TIMMERMANS (Brussels, Belgium)
This page last modified 2019-03
Professional profile    Consulting services    E-mail    Contact

© 2000-